H. Thomas Watkins III

Director at Atterx BioTherapeutics

H. Thomas Watkins III

H. Thomas Watkins III

Director at Atterx BioTherapeutics

Overview
Career Highlights

TAP Pharmaceutical Products, Inc.
Human Genome Sciences, Inc.

RelSci Relationships

2170

Number of Boards

14

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals H. Thomas Watkins III likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at Horizon Therapeutics Plc

Relationship likelihood: Strong

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Co-Founder at Atterx BioTherapeutics

Relationship likelihood: Strong

John Stewart Bryan Professor of Jurisprudence at College of William and Mary - Marshall Wythe Law School

Relationship likelihood: Strong

Former Member, Senior Executive Service at United States Army

Relationship likelihood: Strong

Provost at The College of William & Mary

Relationship likelihood: Strong

Intellia Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Associate Professor & Head-Laboratory Cardiovascular Division at University of Virginia

Relationship likelihood: Strong

Chief Executive Officer at HemoShear LLC

Relationship likelihood: Strong

Paths to H. Thomas Watkins III
Potential Connections via
Relationship Science
You
H. Thomas Watkins III
Director at Atterx BioTherapeutics
Education
BBA

The College of William & Mary in Virginia (also known as The College, William & Mary, or W&M) is a public research university located in Williamsburg, Virginia, United States. Privately founded in 1693 by letters patent issued by King William III and Queen Mary II, it is the second-oldest institution of higher education in the United States after Harvard University.

MBA

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

Career History
Director
Current

Atterx Biotherapeutics, Inc. develops novel antibacterial technologies. It developed two products to fight multi-drug resistant, Gram negative bacteria. The first product, C-1205 utilizes bacterial interference technology to prevent catheter associated urinary tract infections and GN-4474 has been developed using this technology to target Gram negative bacteria. It has been shown to be effective in animal infection models and an IND filing is expected in 2015. The company was founded by Richard R. Burgess and Marcin Filutowicz in 2001 and is headquartered in Madison, WI.

President & Chief Executive Officer
2004 - 2012

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

President
1998 - 2004

TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL.

Boards & Committees
Member, Strategic Advisory Board
2013 - Current

WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD.

Director
2004 - 2012

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Vice Rector, Board of Visitors
Current

The College of William & Mary in Virginia (also known as The College, William & Mary, or W&M) is a public research university located in Williamsburg, Virginia, United States. Privately founded in 1693 by letters patent issued by King William III and Queen Mary II, it is the second-oldest institution of higher education in the United States after Harvard University.

Director
Prior

The United States Chamber of Commerce (USCC) is an American lobbying group representing the interests of many businesses and trade associations. It is not an agency of the United States government. The Chamber is staffed with policy specialists, lobbyists and lawyers. Politically, the Chamber is generally considered to be a conservative organization. It usually supports Republican political candidates, though it has occasionally supported conservative Democrats. The Chamber is one of the largest lobbying groups in the U.S., spending more money than any other lobbying organization on a yearly basis.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2012

The College of William & Mary in Virginia (also known as The College, William & Mary, or W&M) is a public research university located in Williamsburg, Virginia, United States. Privately founded in 1693 by letters patent issued by King William III and Queen Mary II, it is the second-oldest institution of higher education in the United States after Harvard University.

N/A
2005

The College of William & Mary in Virginia (also known as The College, William & Mary, or W&M) is a public research university located in Williamsburg, Virginia, United States. Privately founded in 1693 by letters patent issued by King William III and Queen Mary II, it is the second-oldest institution of higher education in the United States after Harvard University.

N/A
2003

The College of William & Mary in Virginia (also known as The College, William & Mary, or W&M) is a public research university located in Williamsburg, Virginia, United States. Privately founded in 1693 by letters patent issued by King William III and Queen Mary II, it is the second-oldest institution of higher education in the United States after Harvard University.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by H. Thomas Watkins III. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of H. Thomas Watkins III's profile does not indicate a business or promotional relationship of any kind between RelSci and H. Thomas Watkins III.